Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

Stock Information for Avai Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avai Bio Inc.

Foresight: Eye-Net Signs a LOI to Conduct a Large-Scale V2X Pilot Project in the Manila Metropolitan in the Philippines
Foresight Signs an Agreement with a Leading European Car Manufacturer to Advance its Stereo Vision AI-Based Solution
Five Under-the-Radar Stocks With Catalysts Already in Motion - Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security
VisionWave Holdings, Inc. (Nasdaq: VWAV) Corporate Update
The Three-Layer Counter-UAS Stack: VisionWave Assembles RF + Computer Vision + AI Video Analytics Architecture with Foresight Investment
VisionWave Announces Strategic Investment in Foresight Autonomous Holdings and Integration with xClibre(TM) AI Video Intelligence
Foresight Announces Fourth Quarter and Full Year 2025 Financial Results
Foresight's Eye-Net Achieves Positive Results in Large-Scale Public Transit Project with Renault and Orange in France

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.